U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979648) titled 'Effectiveness of Qualia Magnesium+(R) Supplementation on RBC Magnesium Levels' on May 13.
Brief Summary: This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+(R) supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL will be randomly assigned to receive either Qualia Magnesium+ or a placebo. Participants will take 2 capsules daily in the evening, with or without food, for a duration of 12 weeks. The primary outcome is the between-group change in RB...